Literature DB >> 10698711

Alternative splicing for the alpha1 subunit of soluble guanylate cyclase.

D Ritter1, J F Taylor, J W Hoffmann, L Carnaghi, S J Giddings, H Zakeri, P Y Kwok.   

Abstract

Soluble guanylate cyclase (sGC), the receptor for nitric oxide, is a heterodimer consisting of alpha and beta subunits. We investigated the mRNA species for the alpha(1) subunit in human brain, heart, artery and immortalized B-lymphocytes. Three mRNA species were identified in these tissues. The major mRNA species contained the full expression sequence of the alpha(1) subunit. Two other types of mRNA were detected in which 5' sequences were deleted by splicing (506-590 and 412-590). Each of these deletions included the predicted translation start site, indicating that translation of these two alternatively spliced RNA species does not result in the production of full-length alpha(1) subunits. The relative amounts of the two mRNA species with deletions of the translation start site differed significantly between cell lines of immortalized B-lymphocytes from different individuals. sGC enzymic activity was significantly decreased in cellular extracts from cell lines with high proportions of mRNA species containing the deletion 506-590 when compared with extracts from cell lines that contained mostly mRNA without this deletion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698711      PMCID: PMC1220917     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain.

Authors:  G Giuili; U Scholl; F Bulle; G Guellaën
Journal:  FEBS Lett       Date:  1992-06-08       Impact factor: 4.124

2.  Heterogeneity in human soluble guanylate cyclase due to alternative splicing.

Authors:  V Chhajlani; P A Frändberg; J Ahlner; K L Axelsson; J E Wikberg
Journal:  FEBS Lett       Date:  1991-09-23       Impact factor: 4.124

3.  Molecular cloning and expression of a new alpha-subunit of soluble guanylyl cyclase. Interchangeability of the alpha-subunits of the enzyme.

Authors:  C Harteneck; B Wedel; D Koesling; J Malkewitz; E Böhme; G Schultz
Journal:  FEBS Lett       Date:  1991-11-04       Impact factor: 4.124

Review 4.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

5.  A variant of the alpha 2 subunit of soluble guanylyl cyclase contains an insert homologous to a region within adenylyl cyclases and functions as a dominant negative protein.

Authors:  S Behrends; C Harteneck; G Schultz; D Koesling
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

6.  Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function.

Authors:  C Cardillo; C M Kilcoyne; R O Cannon; J A Panza
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690

Review 7.  NO at work.

Authors:  H H Schmidt; U Walter
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

8.  Dominant negative mutants of nitric oxide-sensitive guanylyl cyclase.

Authors:  P S Yuen; L K Doolittle; D L Garbers
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

9.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

Authors:  M Yamamura; K Uyemura; R J Deans; K Weinberg; T H Rea; B R Bloom; R L Modlin
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

10.  Rat insulin II gene expression by extraplacental membranes. A non-pancreatic source for fetal insulin.

Authors:  S J Giddings; L Carnaghi
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

View more
  7 in total

1.  Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity.

Authors:  Iraida G Sharina; Filip Jelen; Elena P Bogatenkova; Anthony Thomas; Emil Martin; Ferid Murad
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

Review 2.  RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase.

Authors:  Iraida G Sharina; Gilbert J Cote; Emil Martin; Marie-Francoise Doursout; Ferid Murad
Journal:  Nitric Oxide       Date:  2011-08-16       Impact factor: 4.427

3.  Genomic organization of alpha1 and beta1 subunits of the mammalian soluble guanylyl cyclase genes.

Authors:  I G Sharina; J S Krumenacker; E Martin; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide.

Authors:  Yasuko Nagasaka; Emmanuel S Buys; Ester Spagnolli; Andrea U Steinbicker; Sarah R Hayton; Kristen M Rauwerdink; Peter Brouckaert; Warren M Zapol; Kenneth D Bloch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-21       Impact factor: 4.733

5.  Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.

Authors:  Sergio de Frutos; Carlos H Nitta; Elizabeth Caldwell; Jessica Friedman; Laura V González Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-10       Impact factor: 5.464

6.  Prolonged exposure of chromaffin cells to nitric oxide down-regulates the activity of soluble guanylyl cyclase and corresponding mRNA and protein levels.

Authors:  Rut Ferrero; Magdalena Torres
Journal:  BMC Biochem       Date:  2002-09-12       Impact factor: 4.059

7.  Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor.

Authors:  Martín L Marro; Concepción Peiró; Catherine M Panayiotou; Reshma S Baliga; Sabine Meurer; Harald H H W Schmidt; Adrian J Hobbs
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.